Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ann Lawson

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The American Journal of Nursing|January 22, 2026
Team Science and Nursing ScholarshipLee Ann Lawson, Sandra Wolfe Citty
Genetic Testing and Molecular Biomarkers|April 12, 2018
Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping AssayTaimour Langaee, Richard Wagner, Lloyd P Horne, et al.
Respiratory Physiology & Neurobiology|June 26, 2013
The respiratory neuromuscular system in Pompe diseaseDavid D Fuller, Mai K ElMallah, Barbara K Smith, et al.
Physical Therapy|February 20, 2016
Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case SeriesBarbara K Smith, David D Fuller, A Daniel Martin, et al.
Muscle & Nerve|September 10, 2015
Respiratory motor function in individuals with centronuclear myopathiesBarbara K Smith, Markus S Renno, Meghan M Green, et al.
Muscle & Nerve|September 5, 2014
Altered activation of the tibialis anterior in individuals with Pompe disease: Implications for motor unit dysfunctionManuela Corti, Barbara K Smith, Darin J Falk, et al.
Mitochondrion|November 14, 2017
Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trialPeter W Stacpoole, Jonathan Shuster, John L P Seamus Thompson, et al.
Experimental Neurology|July 26, 2016
Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticityBarbara K Smith, A Daniel Martin, Lee Ann Lawson, et al.
The Journal of Pediatrics|April 23, 2013
B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe diseaseMelissa E Elder, Sushrusha Nayak, Shelley W Collins, et al.
Molecular Genetics and Metabolism|April 11, 2025
Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extensionUma Ramaswami, Esperanza Font-Montgomery, Ozlem Goker-Alpan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The American Journal of Nursing|January 22, 2026
Team Science and Nursing ScholarshipLee Ann Lawson, Sandra Wolfe Citty
Genetic Testing and Molecular Biomarkers|April 12, 2018
Personalized Dosing of Dichloroacetate Using GSTZ1 Clinical Genotyping AssayTaimour Langaee, Richard Wagner, Lloyd P Horne, et al.
Respiratory Physiology & Neurobiology|June 26, 2013
The respiratory neuromuscular system in Pompe diseaseDavid D Fuller, Mai K ElMallah, Barbara K Smith, et al.
Physical Therapy|February 20, 2016
Diaphragm Pacing as a Rehabilitative Tool for Patients With Pompe Disease Who Are Ventilator-Dependent: Case SeriesBarbara K Smith, David D Fuller, A Daniel Martin, et al.
Muscle & Nerve|September 10, 2015
Respiratory motor function in individuals with centronuclear myopathiesBarbara K Smith, Markus S Renno, Meghan M Green, et al.
Muscle & Nerve|September 5, 2014
Altered activation of the tibialis anterior in individuals with Pompe disease: Implications for motor unit dysfunctionManuela Corti, Barbara K Smith, Darin J Falk, et al.
Mitochondrion|November 14, 2017
Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trialPeter W Stacpoole, Jonathan Shuster, John L P Seamus Thompson, et al.
Experimental Neurology|July 26, 2016
Inspiratory muscle conditioning exercise and diaphragm gene therapy in Pompe disease: Clinical evidence of respiratory plasticityBarbara K Smith, A Daniel Martin, Lee Ann Lawson, et al.
The Journal of Pediatrics|April 23, 2013
B-Cell depletion and immunomodulation before initiation of enzyme replacement therapy blocks the immune response to acid alpha-glucosidase in infantile-onset Pompe diseaseMelissa E Elder, Sushrusha Nayak, Shelley W Collins, et al.
Molecular Genetics and Metabolism|April 11, 2025
Safety and efficacy of migalastat in adolescent patients with Fabry disease: Results from ASPIRE, a phase 3b, open-label, single-arm, 12-month clinical trial, and its open-label extensionUma Ramaswami, Esperanza Font-Montgomery, Ozlem Goker-Alpan, et al.
Pageof 2